Close Menu

Please, Come Back!

Pharmalot's Ed Silverman wonders how pharmaceutical companies will deal with the impending "patent cliffs" they face that will leave them with no patent protection on their most popular drugs. One idea, he says, is to create an atmosphere of customer loyalty, emulating companies like Apple or Starbucks. Writing in BusinessWeek, consultants G.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.